Диссертация (1154785), страница 19
Текст из файла (страница 19)
– p. 412– 419.128100. Ishihara, H. Saito, Relation between ventriculoarterial coupling and myocardialenergetics in patients with idiopathic dilated cardiomyopathy / H. Ishihara, M. Yokota,T. Sobue // J. Am. Coll. Cardiol. – 1994. –vol. 23. – p. 406– 416.101. James, K.B. Blood volume and brain natriuretic peptide in congestive heartfailure: a pilot study / K.B. James, R.W.
Troughton, J. Feldschuh, D. Soltis, D. Thomas,F. Fouad-Tarazi // Am. Heart J. – 2005. – vol. 150(5). – p. 984.102. Jhund, P.S. Efficacy and safety of LCZ696 (sacubitril-valsartan) according toage: insights from PARADIGM HF / P.S. Jhund, M. Fu, E. Bayram, et al. // Eur HeartJ. – 2015. – vol. 36(38). – p. 2576– 2584. 103. Kameyama, T. Ventricular load optimization by unloading therapy in patientswith heart failure / T. Kameyama, H. Asanoi, S.
Ishizaka, S. Sasayama // J Am CollCardiol. – 1991. – vol. 17. – p. 199– 207.104. Kass, D. A. Determinants of end-systolic pressure-volume relations during acuteregional ischemia in situ / D.A. Kass, P. Marino, W.L. Maughan, K. Sagawa //Circulation. - 1989. – vol. 80. - p 1783– 1794.105. Kass, D.A. Ventricular arterial stiffening: integrating the pathophysiology / D.A.Kass // Hypertension. – 2005. - vol. 46.
– p. 185– 193. 106. Kawaguchi, M. Combined ventricular systolic and arterial stiffening in patientswith heart failure and preserved ejection fraction: implications for systolic and diastolicreserve limitations / M. Kawaguchi, I. Hay, B. Fetics, D.A. Kass // Circulation. – 2003.– vol. 107. – p. 714– 720. 107. Kelly, R.P. Effective arterial elastance as index of arterial vascular load inhumans / R.P. Kelly, C.T.
Ting, T.M. Yang, C.P. Liu, W.L. Maughan, M.S. Chang etal. // Circulation. – 1992. - vol. 86. – p. 513– 521. 108. Kelly, R. Effect of reduced aortic compliance on cardiac efficiency andcontractile function of in situ canine left ventricle / R. Kelly, R. Tunin, D. Kass // Circ.Res. - 1992. – vol. 71. – p. 490– 502.129109. Kim, D.B.
Improvement of Arterial Stiffness in the Transition From AcuteDecompensated Heart Failure to Chronic Compensated Heart Failure / D.B. Kim, S.H.Baek, S. W. Jang, S.H. Her, et al. // Clin. Cardiol. – 2013. – vol. 36 (6). – p. 358- 362.110. Kitzman, D. W. Exercise intolerance in patients with heart failure and preservedleft ventricular systolic function: failure of the Frank- Starling mechanism / D.W.Kitzman, M.B. Higginbotham, F.R. Cobb, K.H. Sheikh, M.J. Sullivan // J. Am.
Coll.Cardiol. - 1991. – vol. 17. – p. 1065– 1072.111. Kobalava, Z. First experience with concomitant AT1 and neprilysin inhibitionwith LCZ696 in patients with chronic heart failure / Z. Kobalava, E. Pavlikova, O.Averkov, et al. // Circulation. – 2010. – vol. 122(21 Suppl). - 19378.112. Kobalava, Z. Short-term treatment with LCZ696 in patients with stable chronicheart failure: effect on biomarkers / Z.
Kobalava, P. Jordaan, Y. Kotovskaya et al. //Eur Heart J. – 2013. – vol. 34(Issue suppl 1). - P5716.113. Kostis, J.B. Omapatrilat and enalapril in patients with hypertension: theOmapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial / J.B. Kostis, M.Packer, H.R. Black, R. Schmieder, D.
Henry, E. Levy // Am J Hypertens. - 2004. –vol. 17(2). – p. 103– 111.114. Knaapen, P. Myocardial energetics and efficiency: current status of thenoninvasive approach / P. Knaapen, T. Germans, J. Knuuti, et al. // Circulation. – 2007.– vol. 115. – p. 918– 927.115. Kuhn, M. Endothelial actions of atrial and B-type natriuretic peptides / M. Kuhn// Br J Pharmacol. – 2012. – vol. 166. – p. 522– 531.116. Ky, B. Ventricular-arterial coupling, remodeling, and prognosis in chronic heartfailure / B. Ky, B.
French, A.M. Khan, T. Plappert, A. Wang, J.A. Chirinos et al. // JAm Coll Cardiol. – 2013. – vol. 62. – p. 1165–1672.117. Lakatta, E. G. Arterial and cardiac aging: major shareholders in cardiovasculardisease enterprises. Part II: the aging heart in health: links to heart disease /. E.G.Lakatta, D.
Levy // Circulation. -2003. – vol. 107. – p. 346– 354.130118. Lakatta, E. G. Arterial and cardiac aging: major shareholders in cardiovasculardisease enterprises. Part III: cellular and molecular clues to heart and arterial aging /E.G. Lakatta // Circulation.
– 2003. – vol. 107. – p. 490– 497.119. Lakatta, E. G. Cardiovascular regulatory mechanisms in advanced age / E.G.Lakatta // Physiol. Rev. - 1993. – vol. 73. – p. 413– 467.120. Lala, R.I. Galectin-3: A Link between Myocardial and Arterial Stiffening inPatients with Acute Decompensated Heart Failure? / R.I. Lala, D. Darabantiu, L. Pilat,M.
Puschita // Arq Bras Cardiol. – 2016. – vol. 106(2). – p. 121- 129.121. Lam, C.S. Cardiac structure and ventricular-vascular function in persons withheart failure and preserved ejection fraction from Olmsted County, Minnesota / C.S.Lam, V.L. Roger, R.J. Rodeheffer, F. Bursi, B.A. Borlaug, S.R. Ommen et al. //Circulation. – 2007. – vol. 115.
– p. 1982– 1990. 122. Lam, C.S. Effect of antihypertensive therapy on ventricular-arterial mechanics,coupling, and efficiency / C.S. Lam, A.M. Shah, B.A. Borlaug, S. Cheng, A. Verma,J. Izzo et al. // Eur Heart J. – 2013. – vol. 34. – p. 676– 683.123. Lang, R.M. Recommendations for chamber quantification / R.M. Lang, M.Bierig, R.B.
Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka et al. // Eur JEchocardiogr. – 2006. – vol. 7. – p. 79– 108.124. Lage, S.G. Carotid arterial compliance in patients with congestive heart failuresecondary to idiopathic dilated cardiomyopathy / S.G. Lage, L. Kopel, M.C.Monachini, et al. // Am J Cardiol. – 1994. – vol. 74. – p. 691– 695.125. Laskey, W.K. Characteristics of vascular hydraulic load in patients with heartfailure / W.K. Laskey, W.G.
Kussmaul, J.L. Martin, et al. // Circulation. – 1985. – vol.72. – p. 61– 71.126. Laurent, S.Aortic stiffness is an independent predictor of all-cause andcardiovascular mortality in hypertensive patients / S. Laurent, P. Boutouyrie, R. Asmar,et al. // Hypertension. – 2001. – vol. 37. – p. 1236– 1241.127. Levin, E.R. Natriuretic peptides / E.R. Levin, D.G. Gardner, W.K. Samson // NEngl J Med. – 1998. – vol. 339. – p.
321– 328.131128. Little, W. C. Effect of exercise on left ventricular-arterial coupling assessed inthe pressure-volume plane / W.C. Little, C.P. Cheng // Am. J. Physiol. – 1993. –vol.264. - H1629– H1633. 129. Little, W. C. Left ventricular-arterial coupling in conscious dogs / W.C.
Little,C.P. Cheng // Am. J. Physiol. – 1991. – vol. 261. - H70– H76.130. Lloyd-Jones, D. Heart disease and stroke statistics – 2010 update. A report fromthe American Heart Association / D. Lloyd-Jones, R.J. Adams, T.M. Brown, et al. //Circulation. – 2009.
– vol. 121. - e1–e170.131. Mancia, G. Strain Echocardiography in Acute Cardiovascular Diseases / G.Manica, R. Fagard, K. Narkiewicz, et al. // West J Emerg Med. – 2016. – vol. 17(1). –p. 54– 60.132. Mangiafico, S. Neutral endopeptidase inhibition and the natriuretic peptidesystem: an evolving strategy in cardiovascular therapeutics / S. Mangiafico, L.C.Costello-Boerrigter, I.A. Andersen, A. Cataliotti, J.C. Burnett Jr // Eur Heart J. – 2013.– vol. 34. – p. 886-893.133.
Masai, T. Hepatic dysfunction after left ventricular mechanical assist in patientswith end-stage heart failure: role of inflammatory response and hepaticmicrocirculation / T. Masai, Y. Sawa, S. Ohtake, et al. // Ann Thorac Surg. – 2002. –vol. 73. – p. 549– 555.134. Maurer, M. S. Left heart failure with a normal ejection fraction: identificationof different patho- physiologic mechanisms / M.S. Maurer, D.L. King, L. El-KhouryRumbarger, M. Packer, D. Burk- hoff // J. Card. Fail. – 2005. – vol. 11. – p.177– 187.135.
Maurin, V. Early reverse remodeling and improvement of echo parameters afterintroduction of sacubitril/valsartan in 80 stable and well treated HFrEF patients / V.Maurin, A. Canu, A. Bernard, et al. // Eur J Heart Failure. – 2017. – vol. 19(Suppl. 1).– p. 296(P1189).136. McEniery, C.M. Central blood pressure: current evidence and clinicalimportance / C.M. McEniery, J.R. Cockcroft, M.J. Roman, et al. // Eur Heart J.
– 2014.– vol. 35. – p. 1719- 1725.132137. McKie, P.M. M-atrial natriuretic peptide: a novel antihypertensive proteintherapy / P.M. McKie, T. Ichiki, J.C. Burnett Jr. // Curr Hypertens Rep. - 2012. – vol.14. – p. 62– 69.138. McMurray, Angiotensin-neprilysin inhibition versus enalapril in heart failure /J.
McMurray, M. Packer, A. Desai, et al. // N Engl J Med. – 2014. – vol. 371(11). – p.993– 1004.139. McMurray, J. Neprilisin inhibition to treat heart failure: a tale of science,serendipity, and second chances / J. McMurray // Eur J Heart Fail. – 2015. – vol. 17. –p. 242– 247. 140. Mendonza, A. Assessment of pharmacokinetic drug interaction betweenLCZ696 and metformin / A. Mendonza, A. Mizuki, T. Langenickel, et al. //Hypertension. – 2013.
– vol. 62. - A456.141. Mitchell, G.F. Pulsatile hemodynamics in congestive heart failure / G.F.Mitchell, J.C. Tardif, J.M. Arnold, et al. // Hypertension. – 2001. – vol. 38. – p. 1433–1439.142. Mor-Avi, V. Current and evolving echocardiographic techniques for thequantitative evaluation of cardiac mechanics: ASE/EAE consensus statement onmethodology and indications / V.
Mor-Avi, R.M. Lang, L.P. Badano, et al. // J Am SocEchocardiogr. – 2011. –vol. 24. – p. 277– 313. 143. Mosterd, A. Clinical epidemiology of heart failure / A. Mosterd, A.W. Hoes //Heart. – 2007. – vol. 93. – p. 1137– 1146.144. Mozaffarian, D. American Heart Association Statistics Committee and StrokeStatistics Subcommittee. Heart disease and stroke statistics — 2015 update: a reportfrom the American Heart Association / D. Mozaffarian, E.J. Benjamin, A.S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
